Hossein Borghaei, DO, MS, Expresses Interest in DESTINY-Lung-1 Trial of Trastuzumab Deruxtecan in NSCLC

Press/Media

Period	Nov 15 2021

Media coverage

Title	Hossein Borghaei, DO, MS, Expresses Interest in DESTINY-Lung-1 Trial of Trastuzumab Deruxtecan in NSCLC
Media name/outlet	NewsBreak
Country/Territory	United States
Date	11/15/21
URL	https://www.newsbreak.com/news/2434615179831/hossein-borghaei-do-ms-expresses-interest-in-destiny-lung-1-trial-of-trastuzumab-deruxtecan-in-nsclc
Persons	Hossein Borghaei